The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Bone and Mineral Diagnostic Testing-Global Market Insights and Sales Trends 2024
Synopsis
Bone and mineral metabolism disorder is a collective term used to describe various conditions that make bones weak. Bone mineral metabolism maintains sufficient concentration of inorganic ions in blood serum. Progressive chronic kidney disease, especially end-stage renal disease (ESRD), is responsible for adverse changes in bone and mineral metabolism. Increase in serum parathyroid hormone levels due to fall in glomerular filtration rate is an indicator of bone disorder caused by chronic kidney disease. Reduction in kidney function leads to changes in bone mineral homeostasis and in levels of parathyroid hormone (PTH), 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and fibroblast growth factor-23 (FGF-23). Disorders of mineral metabolism in chronic kidney disease (CKD) have been associated with higher mortality than anemia and inadequate dialysis.
The global Bone and Mineral Diagnostic Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Bone and Mineral Diagnostic Testing in various end use industries. The expanding demands from the Vitamin D Testing and Bone Metabolism, are propelling Bone and Mineral Diagnostic Testing market. Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Assays/Consumables segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bone and Mineral Diagnostic Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bone and Mineral Diagnostic Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bone and Mineral Diagnostic Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bone and Mineral Diagnostic Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bone and Mineral Diagnostic Testing covered in this report include Abbott Diagnostics, bioMérieux, Diasorin, Roche Diagnostic, Siemens Healthcare and Quidel, etc.
The global Bone and Mineral Diagnostic Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Diagnostics
bioMérieux
Diasorin
Roche Diagnostic
Siemens Healthcare
Quidel
Global Bone and Mineral Diagnostic Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bone and Mineral Diagnostic Testing market, Segment by Type:
Instruments
Assays/Consumables
Global Bone and Mineral Diagnostic Testing market, by Application
Vitamin D Testing
Bone Metabolism
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bone and Mineral Diagnostic Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Bone and mineral metabolism disorder is a collective term used to describe various conditions that make bones weak. Bone mineral metabolism maintains sufficient concentration of inorganic ions in blood serum. Progressive chronic kidney disease, especially end-stage renal disease (ESRD), is responsible for adverse changes in bone and mineral metabolism. Increase in serum parathyroid hormone levels due to fall in glomerular filtration rate is an indicator of bone disorder caused by chronic kidney disease. Reduction in kidney function leads to changes in bone mineral homeostasis and in levels of parathyroid hormone (PTH), 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and fibroblast growth factor-23 (FGF-23). Disorders of mineral metabolism in chronic kidney disease (CKD) have been associated with higher mortality than anemia and inadequate dialysis.
The global Bone and Mineral Diagnostic Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Bone and Mineral Diagnostic Testing in various end use industries. The expanding demands from the Vitamin D Testing and Bone Metabolism, are propelling Bone and Mineral Diagnostic Testing market. Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Assays/Consumables segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bone and Mineral Diagnostic Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bone and Mineral Diagnostic Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bone and Mineral Diagnostic Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bone and Mineral Diagnostic Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bone and Mineral Diagnostic Testing covered in this report include Abbott Diagnostics, bioMérieux, Diasorin, Roche Diagnostic, Siemens Healthcare and Quidel, etc.
The global Bone and Mineral Diagnostic Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Diagnostics
bioMérieux
Diasorin
Roche Diagnostic
Siemens Healthcare
Quidel
Global Bone and Mineral Diagnostic Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bone and Mineral Diagnostic Testing market, Segment by Type:
Instruments
Assays/Consumables
Global Bone and Mineral Diagnostic Testing market, by Application
Vitamin D Testing
Bone Metabolism
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bone and Mineral Diagnostic Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Bone and Mineral Diagnostic Testing
1.1 Bone and Mineral Diagnostic Testing Market Overview
1.1.1 Bone and Mineral Diagnostic Testing Product Scope
1.1.2 Bone and Mineral Diagnostic Testing Market Status and Outlook
1.2 Global Bone and Mineral Diagnostic Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Bone and Mineral Diagnostic Testing Market Size by Region (2018-2029)
1.4 Global Bone and Mineral Diagnostic Testing Historic Market Size by Region (2018-2023)
1.5 Global Bone and Mineral Diagnostic Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Bone and Mineral Diagnostic Testing Market Size (2018-2029)
1.6.1 North America Bone and Mineral Diagnostic Testing Market Size (2018-2029)
1.6.2 Europe Bone and Mineral Diagnostic Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Bone and Mineral Diagnostic Testing Market Size (2018-2029)
1.6.4 Latin America Bone and Mineral Diagnostic Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Bone and Mineral Diagnostic Testing Market Size (2018-2029)
2 Bone and Mineral Diagnostic Testing Market by Type
2.1 Introduction
2.1.1 Instruments
2.1.2 Assays/Consumables
2.2 Global Bone and Mineral Diagnostic Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Bone and Mineral Diagnostic Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Bone and Mineral Diagnostic Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Bone and Mineral Diagnostic Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Bone and Mineral Diagnostic Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Bone and Mineral Diagnostic Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Bone and Mineral Diagnostic Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Bone and Mineral Diagnostic Testing Revenue Breakdown by Type (2018-2029)
3 Bone and Mineral Diagnostic Testing Market Overview by Application
3.1 Introduction
3.1.1 Vitamin D Testing
3.1.2 Bone Metabolism
3.2 Global Bone and Mineral Diagnostic Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Bone and Mineral Diagnostic Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Bone and Mineral Diagnostic Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Bone and Mineral Diagnostic Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Bone and Mineral Diagnostic Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Bone and Mineral Diagnostic Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Bone and Mineral Diagnostic Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Bone and Mineral Diagnostic Testing Revenue Breakdown by Application (2018-2029)
4 Bone and Mineral Diagnostic Testing Competition Analysis by Players
4.1 Global Bone and Mineral Diagnostic Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bone and Mineral Diagnostic Testing as of 2022)
4.3 Date of Key Players Enter into Bone and Mineral Diagnostic Testing Market
4.4 Global Top Players Bone and Mineral Diagnostic Testing Headquarters and Area Served
4.5 Key Players Bone and Mineral Diagnostic Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Bone and Mineral Diagnostic Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Diagnostics
5.1.1 Abbott Diagnostics Profile
5.1.2 Abbott Diagnostics Main Business
5.1.3 Abbott Diagnostics Bone and Mineral Diagnostic Testing Products, Services and Solutions
5.1.4 Abbott Diagnostics Bone and Mineral Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Diagnostics Recent Developments
5.2 bioMérieux
5.2.1 bioMérieux Profile
5.2.2 bioMérieux Main Business
5.2.3 bioMérieux Bone and Mineral Diagnostic Testing Products, Services and Solutions
5.2.4 bioMérieux Bone and Mineral Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.2.5 bioMérieux Recent Developments
5.3 Diasorin
5.3.1 Diasorin Profile
5.3.2 Diasorin Main Business
5.3.3 Diasorin Bone and Mineral Diagnostic Testing Products, Services and Solutions
5.3.4 Diasorin Bone and Mineral Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Diagnostic Recent Developments
5.4 Roche Diagnostic
5.4.1 Roche Diagnostic Profile
5.4.2 Roche Diagnostic Main Business
5.4.3 Roche Diagnostic Bone and Mineral Diagnostic Testing Products, Services and Solutions
5.4.4 Roche Diagnostic Bone and Mineral Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Diagnostic Recent Developments
5.5 Siemens Healthcare
5.5.1 Siemens Healthcare Profile
5.5.2 Siemens Healthcare Main Business
5.5.3 Siemens Healthcare Bone and Mineral Diagnostic Testing Products, Services and Solutions
5.5.4 Siemens Healthcare Bone and Mineral Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Siemens Healthcare Recent Developments
5.6 Quidel
5.6.1 Quidel Profile
5.6.2 Quidel Main Business
5.6.3 Quidel Bone and Mineral Diagnostic Testing Products, Services and Solutions
5.6.4 Quidel Bone and Mineral Diagnostic Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Quidel Recent Developments
6 North America
6.1 North America Bone and Mineral Diagnostic Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Bone and Mineral Diagnostic Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Bone and Mineral Diagnostic Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Bone and Mineral Diagnostic Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Bone and Mineral Diagnostic Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Bone and Mineral Diagnostic Testing Market Dynamics
11.1 Bone and Mineral Diagnostic Testing Industry Trends
11.2 Bone and Mineral Diagnostic Testing Market Drivers
11.3 Bone and Mineral Diagnostic Testing Market Challenges
11.4 Bone and Mineral Diagnostic Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
